|
Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas BollykyThe Atlantic Apr. 14, 2013 |
Popular 
Sen. Hawley: Send National Guard to Crush Pro-Palestine Protests Like 'Eisenhower Sent the 101st to Little Rock'
Mistrial Declared in Case of Arizona Rancher Accused of Killing Migrant Trespasser
AP: 'Israeli Strikes on Gaza City of Rafah Kill 22, Mostly Children, as U.S. Advances Aid Package'
John Podhoretz Demands National Guard Be Sent Into Columbia U to Put Down Pro-Palestine Protests
House Passes $95B Foreign Aid Giveaway to Israel, Ukraine and Taiwan, Combined With TikTok Ban
 Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India? It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India. Read More 
|
